 |
Priothera
Last updated: September 13, 2024
Florent Gros, CEO
Ireland | Funding: €49M (+)
Website: https://priothera.com
Priothera is dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
Website: https://priothera.com
Priothera is dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
